Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights and Forecast to 2028

Report ID: 1538392 | Published Date: Apr 2026 | No. of Page: 127 | Base Year: 2025 | Rating: 5
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Analgesic & Pain Relievers
        1.2.3 Dermatological Products
        1.2.4 Cough, Cold, and Flu Products
        1.2.5 Vitamin Supplements
        1.2.6 Mineral Supplements
        1.2.7 Ophthalmic Products
    1.3 Market by Application
        1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacy
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2017-2028)
    2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
        2.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2017-2022)
        2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2023-2028)
    2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
        2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
        2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
        2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
        2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue
        3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2017-2022)
        3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2017-2022)
    3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue
    3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio
        3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2021
    3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served
    3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
    3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
    4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2017-2022)
    4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2023-2028)
5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
    5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2017-2022)
    5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)
    6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
        6.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)
        6.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)
        6.2.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
    6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
        6.3.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)
        6.3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)
        6.3.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
    6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
        6.4.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)
        6.4.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)
    7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
        7.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)
        7.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)
        7.2.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
    7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
        7.3.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)
        7.3.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)
        7.3.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
    7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
        7.4.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)
        7.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)
    8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
        8.2.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
    8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
        8.3.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
    8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region
        8.4.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)
    9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
        9.2.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)
        9.2.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)
        9.2.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
    9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
        9.3.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)
        9.3.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)
        9.3.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
    9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
        9.4.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)
        9.4.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2017-2028)
    10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
        10.2.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type (2017-2028)
    10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
        10.3.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application (2017-2028)
    10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country
        10.4.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer Inc.
        11.1.1 Pfizer Inc. Company Details
        11.1.2 Pfizer Inc. Business Overview
        11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.1.5 Pfizer Inc. Recent Developments
    11.2 Novartis International AG
        11.2.1 Novartis International AG Company Details
        11.2.2 Novartis International AG Business Overview
        11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.2.5 Novartis International AG Recent Developments
    11.3 Roche Holding AG
        11.3.1 Roche Holding AG Company Details
        11.3.2 Roche Holding AG Business Overview
        11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.3.5 Roche Holding AG Recent Developments
    11.4 Merck & Co., Inc.
        11.4.1 Merck & Co., Inc. Company Details
        11.4.2 Merck & Co., Inc. Business Overview
        11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.4.5 Merck & Co., Inc. Recent Developments
    11.5 Sanofi S.A
        11.5.1 Sanofi S.A Company Details
        11.5.2 Sanofi S.A Business Overview
        11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.5.5 Sanofi S.A Recent Developments
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.6.5 Johnson & Johnson Recent Developments
    11.7 Gilead Sciences
        11.7.1 Gilead Sciences Company Details
        11.7.2 Gilead Sciences Business Overview
        11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.7.5 Gilead Sciences Recent Developments
    11.8 GlaxoSmithKline plc.
        11.8.1 GlaxoSmithKline plc. Company Details
        11.8.2 GlaxoSmithKline plc. Business Overview
        11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.8.5 GlaxoSmithKline plc. Recent Developments
    11.9 Bayer Healthcare AG
        11.9.1 Bayer Healthcare AG Company Details
        11.9.2 Bayer Healthcare AG Business Overview
        11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.9.5 Bayer Healthcare AG Recent Developments
    11.10 AstraZeneca plc.
        11.10.1 AstraZeneca plc. Company Details
        11.10.2 AstraZeneca plc. Business Overview
        11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.10.5 AstraZeneca plc. Recent Developments
    11.11 Alacer Corp.
        11.11.1 Alacer Corp. Company Details
        11.11.2 Alacer Corp. Business Overview
        11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.11.5 Alacer Corp. Recent Developments
    11.12 Alcon Inc.
        11.12.1 Alcon Inc. Company Details
        11.12.2 Alcon Inc. Business Overview
        11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.12.5 Alcon Inc. Recent Developments
    11.13 Alfresa Pharma Corporation
        11.13.1 Alfresa Pharma Corporation Company Details
        11.13.2 Alfresa Pharma Corporation Business Overview
        11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.13.5 Alfresa Pharma Corporation Recent Developments
    11.14 Alkalon A/S
        11.14.1 Alkalon A/S Company Details
        11.14.2 Alkalon A/S Business Overview
        11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.14.5 Alkalon A/S Recent Developments
    11.15 Alliance Healthcare
        11.15.1 Alliance Healthcare Company Details
        11.15.2 Alliance Healthcare Business Overview
        11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.15.5 Alliance Healthcare Recent Developments
    11.16 Allergan, Plc.
        11.16.1 Allergan, Plc. Company Details
        11.16.2 Allergan, Plc. Business Overview
        11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.16.5 Allergan, Plc. Recent Developments
    11.17 Reckitt Benckiser Plc.
        11.17.1 Reckitt Benckiser Plc. Company Details
        11.17.2 Reckitt Benckiser Plc. Business Overview
        11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.17.5 Reckitt Benckiser Plc. Recent Developments
    11.18 Bausch & Lomb
        11.18.1 Bausch & Lomb Company Details
        11.18.2 Bausch & Lomb Business Overview
        11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.18.5 Bausch & Lomb Recent Developments
    11.19 AbbVie Inc.
        11.19.1 AbbVie Inc. Company Details
        11.19.2 AbbVie Inc. Business Overview
        11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.19.5 AbbVie Inc. Recent Developments
    11.20 The Colgate-Palmolive Company
        11.20.1 The Colgate-Palmolive Company Company Details
        11.20.2 The Colgate-Palmolive Company Business Overview
        11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
        11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
        11.20.5 The Colgate-Palmolive Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Analgesic & Pain Relievers
    Table 3. Key Players of Dermatological Products
    Table 4. Key Players of Cough, Cold, and Flu Products
    Table 5. Key Players of Vitamin Supplements
    Table 6. Key Players of Mineral Supplements
    Table 7. Key Players of Ophthalmic Products
    Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2017-2022)
    Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2023-2028)
    Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
    Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
    Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
    Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
    Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Players (2017-2022)
    Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2021)
    Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
    Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2017-2022)
    Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2023-2028)
    Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2017-2022)
    Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2023-2028)
    Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2023-2028) & (US$ Million)
    Table 65. Pfizer Inc. Company Details
    Table 66. Pfizer Inc. Business Overview
    Table 67. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 68. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 69. Pfizer Inc. Recent Developments
    Table 70. Novartis International AG Company Details
    Table 71. Novartis International AG Business Overview
    Table 72. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 73. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 74. Novartis International AG Recent Developments
    Table 75. Roche Holding AG Company Details
    Table 76. Roche Holding AG Business Overview
    Table 77. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 78. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 79. Roche Holding AG Recent Developments
    Table 80. Merck & Co., Inc. Company Details
    Table 81. Merck & Co., Inc. Business Overview
    Table 82. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 83. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 84. Merck & Co., Inc. Recent Developments
    Table 85. Sanofi S.A Company Details
    Table 86. Sanofi S.A Business Overview
    Table 87. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 88. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 89. Sanofi S.A Recent Developments
    Table 90. Johnson & Johnson Company Details
    Table 91. Johnson & Johnson Business Overview
    Table 92. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 93. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 94. Johnson & Johnson Recent Developments
    Table 95. Gilead Sciences Company Details
    Table 96. Gilead Sciences Business Overview
    Table 97. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 98. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 99. Gilead Sciences Recent Developments
    Table 100. GlaxoSmithKline plc. Company Details
    Table 101. GlaxoSmithKline plc. Business Overview
    Table 102. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 103. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 104. GlaxoSmithKline plc. Recent Developments
    Table 105. Bayer Healthcare AG Company Details
    Table 106. Bayer Healthcare AG Business Overview
    Table 107. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 108. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 109. Bayer Healthcare AG Recent Developments
    Table 110. AstraZeneca plc. Company Details
    Table 111. AstraZeneca plc. Business Overview
    Table 112. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 113. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 114. AstraZeneca plc. Recent Developments
    Table 115. Alacer Corp. Company Details
    Table 116. Alacer Corp. Business Overview
    Table 117. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 118. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 119. Alacer Corp. Recent Developments
    Table 120. Alcon Inc. Company Details
    Table 121. Alcon Inc. Business Overview
    Table 122. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 123. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 124. Alcon Inc. Recent Developments
    Table 125. Alfresa Pharma Corporation Company Details
    Table 126. Alfresa Pharma Corporation Business Overview
    Table 127. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 128. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 129. Alfresa Pharma Corporation Recent Developments
    Table 130. Alkalon A/S Company Details
    Table 131. Alkalon A/S Business Overview
    Table 132. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 133. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 134. Alkalon A/S Recent Developments
    Table 135. Alliance Healthcare Company Details
    Table 136. Alliance Healthcare Business Overview
    Table 137. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 138. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 139. Alliance Healthcare Recent Developments
    Table 140. Allergan, Plc. Company Details
    Table 141. Allergan, Plc. Business Overview
    Table 142. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 143. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 144. Allergan, Plc. Recent Developments
    Table 145. Reckitt Benckiser Plc. Company Details
    Table 146. Reckitt Benckiser Plc. Business Overview
    Table 147. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 148. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 149. Reckitt Benckiser Plc. Recent Developments
    Table 150. Bausch & Lomb Company Details
    Table 151. Bausch & Lomb Business Overview
    Table 152. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 153. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 154. Bausch & Lomb Recent Developments
    Table 155. AbbVie Inc. Company Details
    Table 156. AbbVie Inc. Business Overview
    Table 157. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 158. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 159. AbbVie Inc. Recent Developments
    Table 160. The Colgate-Palmolive Company Company Details
    Table 161. The Colgate-Palmolive Company Business Overview
    Table 162. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product
    Table 163. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022) & (US$ Million)
    Table 164. The Colgate-Palmolive Company Recent Developments
    Table 165. Research Programs/Design for This Report
    Table 166. Key Data Information from Secondary Sources
    Table 167. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2021 VS 2028
    Figure 2. Analgesic & Pain Relievers Features
    Figure 3. Dermatological Products Features
    Figure 4. Cough, Cold, and Flu Products Features
    Figure 5. Vitamin Supplements Features
    Figure 6. Mineral Supplements Features
    Figure 7. Ophthalmic Products Features
    Figure 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2021 VS 2028
    Figure 9. Hospital Pharmacies Case Studies
    Figure 10. Retail Pharmacies Case Studies
    Figure 11. Online Pharmacy Case Studies
    Figure 12. Others Case Studies
    Figure 13. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
    Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2021 VS 2028
    Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2021
    Figure 18. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2021
    Figure 20. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)
    Figure 22. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)
    Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)
    Figure 24. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)
    Figure 30. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Region (2017-2028)
    Figure 40. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)
    Figure 50. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Share by Country (2017-2028)
    Figure 56. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 60. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 61. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 62. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 63. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 65. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 67. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 68. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 69. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 70. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 71. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 72. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 73. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 74. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 75. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 76. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 77. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 78. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Frequently Asked Questions
Over the Counter (OTC) Drugs & Dietary Supplements report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Over the Counter (OTC) Drugs & Dietary Supplements report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Over the Counter (OTC) Drugs & Dietary Supplements report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Oxo Alcohol

Oxo Alcohol market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

P2P Payment

P2P Payment market is segmented by players, region (country), by Type and by Application. Players ... Read More